Ruihua Zhao
No ORCID on file
· 21 papers in corpus
· active 2012-2026
Study types
- article 12
- other 3
- preprint 3
- review 3
Condition tags
- endometriosis 15
- mesh:D004715 9
- dysmenorrhea 6
- adenomyosis 6
- mesh:D004412 4
- infertility 4
- mesh:D017699 2
- endometrioma 1
- dyspareunia 1
Top journals
Frequent coauthors
- Yong Liu 8
- Yingjie Zhang 6
- Xiao-Yun Wang 6
- XinChun Yang 5
- Wei-Wei Sun 5
- Liu Y 4
- Yizhou Fu 4
- Ruijie Hou 3
- Weisen Fan 3
- Guang Shi 3
article
2026
preprint
2026
other
2025
OBJECTIVE: To explore factors related to dysmenorrhea in adenomyosis and construct a risk prediction model. METHODS: A cross-sectional survey involving 1636 adenomyosis patients from 37 hospitals nationwide (November 2019-February 2022) wa…
article
2025
Ovarian endometriosis(OEM) is the most common type of endometriosis, but there is still a lack of simple and easy-to-promote animal models. Therefore, it is necessary to establish a feasible animal model of OEM and analyze its pathogenesis.…
review
2025
This study aims to systematically review and evaluate the quality of clinical research on the treatment of adenomyosis(AM) with traditional Chinese medicine(TCM) in recent ten years, using evidence graphs. Computer searches were conducted o…
article
2025
other
2025
OBJECTIVE: This study aimed to explore the differences in symptom clusters of adenomyosis (AM) patients across spatial, temporal, and age-stratified dimensions based on the theory of "Treatment in Accordance with Three Categories of Etiolog…
other
2025
BACKGROUND: Endometriosis is frequently treated with Paeoniae Radix. It contains Tellimagrandin II, which has the role of modulating immunity and anti-tumor. Therefore, we will explore the effects of Tellimagrandin II on the apoptosis and i…
preprint
2024
review
2023
Current medical treatments for endometriosis-associated pain (EAP) have limitations, including symptom recurrence and hormonal side effects. For this reason, it is important to elucidate any alternative or complementary treatments available…
article
2023
This study aims to analyze the outcomes and measurements of randomized controlled trial(RCT) for traditional Chinese medicine(TCM) treatment of endometriosis(EM) and provide a basis for the building of the core outcome set(COS) of EM. The R…
article
2023
PURPOSE: Exploring the status and related factors of postoperative recurrence of ovarian endometriosis. METHODS: This study analyzed the results of questionnaires conducted in 27 hospitals across the country from January 2019 to November 20…
article
2022
Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Chinese herbal medicine (CHM) has been used for endometriosis for many years in Asian populations. This is a retrospective study in a territo…
article
2020
preprint
2020
Abstract Background: Endometriosis(EM) is a common disease that occurs in reproductive age. 50% endometriosis patients is suffering from infertility. Follicular development is the main cause of endometriosis-associated infertility. Here the…
article
2019
review
2018
article
2016
Objective To assess the clinical effects and safety of Chinese herbal treatment compared with GnRH-a for preventing the post-operative recurrence of pelvic endometriosis. Methods The relative randomized controlled trials (RCTs) of Ch…
article
2015
Background: Endometriosis is a common gynecological disease, which can seriously affect the physical and mental health of patients. However, there is not a satisfactory way to treat endometriosis with a low recurrence rate. Materials and …
article
2013
Traditional Chinese medicine in the treatment of endometriosis has unique advantages through the overall adjustment and many ways.It has reliable efficacy,few side effects,and does not affect the normal endometrial physiology.This paper sum…
article
2012